Mylan gets FDA approval of blood pressure drug
Mylan Inc. said on Tuesday that it gained Food and Drug Administration approval for a generic blood pressure drug.
Cecil-based Mylan said it has started shipping Sildenafil Citrate tablets, the generic version of Pfizer Inc.'s Revatio.
Revatio had U.S. sales of $338.7 million in the 12 months ended Sept. 30.
Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or firstname.lastname@example.org.
Add Alex Nixon to your Google+ circles.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Starkey: Rutherford hits jackpot with Kessel
- Rossi: Wild Wednesday proves Steelers rule
- 2B Walker, Pirates smash through Tigers pitching in road victory
- Penguins get their man in making trade with Toronto for Kessel
- Penguins notebook: Rutherford proves savvy in deal
- Pirates notebook: Cole cool about hostile comment
- Judge revokes bail for Plum High School teacher
- New Kensington residents rally in support of 82-year-old robbery victim
- Pittsburgh a big draw for tourists on July 4th weekend
- Steelers submit application to play host to Super Bowl in 2023
- Ligonier Township officer’s widow to file civil suit